Clinical impact of splicing in neurodevelopmental disorders
Open Access
- 24 April 2020
- journal article
- editorial
- Published by Springer Nature in Genome Medicine
- Vol. 12 (1) , 1-5
Abstract
Clinical exome sequencing is frequently used to identify gene-disrupting variants in individuals with neurodevelopmental disorders. While splice-disrupting variants are known to contribute to these disorders, clinical interpretation of cryptic splice variants outside of the canonical splice site has been challenging. Here, we discuss papers that improve such detection.Keywords
Funding Information
- Simons Foundation Autism Research Initiative (574598, 647371)
This publication has 10 references indexed in Scilit:
- Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of AutismCell, 2020
- Patient-Customized Oligonucleotide Therapy for a Rare Genetic DiseaseNew England Journal of Medicine, 2019
- Pathogenicity and selective constraint on variation near splice sitesGenome Research, 2018
- Base-specific mutational intolerance near splice sites clarifies the role of nonessential splice nucleotidesGenome Research, 2018
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular AtrophyNew England Journal of Medicine, 2017
- Genetic effects on gene expression across human tissuesNature, 2017
- Cryo-electron microscopy snapshots of the spliceosome: structural insights into a dynamic ribonucleoprotein machineNature Structural & Molecular Biology, 2017
- Prevalence and architecture of de novo mutations in developmental disordersNature, 2017
- Analysis of protein-coding genetic variation in 60,706 humansNature, 2016
- Clinical Exome Sequencing for Genetic Identification of Rare Mendelian DisordersJAMA, 2014